Imaging Market Share Analysis Shows 28% of Image Interpretation Performed by Non-Radiologists

A new Harvey L. Neiman Health Policy Institute study found that radiologists interpreted 72.1% of all imaging studies for Medicare fee-for-service beneficiaries in 2022, with the remaining 27.9% performed by other types of clinicians.

Scientists Recruit New Atomic Heavyweights in Targeted Fight Against Cancer

Researchers from Berkeley Lab and Los Alamos National Laboratory have developed new methods for the large-scale production, purification, and use of the radioisotope cerium-134, which could serve as a PET imaging radiotracer for a highly targeted cancer treatment known as alpha-particle therapy.